During the first five years (2002- 2007), the company focused on creating new technologies for isolation, growth and biomonitoring "biomining" microorganisms, generating successful processes to bioleach copper contained in secondary and primary sulfide ores. During that period, more than 100 patent applications were filed, a multidisciplinary team was formed and a world class infrastructure was installed with the aim of developing bioleaching technologies. Over the next five years (2008-2012), the company began technology transference and field validations of the developed bioleaching technologies at diverse mining sites. We operate in Andina Division of CODELCO; at 4.000 meters height and below zero temperatures, and also at División Radomiro Tomic of CODELCO, in the Atacama Desert. Today, after 12 years of research and development dedicated to the generation of bioleaching processes of primary copper sulfides, we have managed to validate our technologies in an industrial operation at Radomiro Tomic Division of CODELCO Chile. The results of copper extraction from predominantly primary minerals (chalcopyrite/ bornite) are between 30-50% more copper than conventional bioleaching (using native microorganisms). The main technological breakthrough of this technology is the dissolution, at environmental temperature, of copper contained in chalcopyrite and bornite, very abundant mineralogical species in the nature, but very difficult to bioleach. Since February 2015 BioSigma is operating with a commercial contract with Codelco's Radomiro Tomic Division for processing low-grade sulfide ores (LGS) that will last three years. BioSigma thus faces a new challenge: Develop new business opportunities and be economically sustainable. Mission
| Website | http://www.biosigma.cl |
| Revenue | $200000 |
| Employees | View employees |
| Address | 106 Los Libertadores Colina, Santiago, Santiago Metropolitan, CL |
| Phone | +56 2 2437 9030 |
| Industry | Retail |
| Competitors | BASF, ADM, Agilent Technologies, DuPont, Corteva Agriscience, Evonik, Novozymes, Geno, Zymergen, Inc. +47 more (view full list) |
| SIC | SIC Code 58 Companies, SIC Code 581 Companies |
| NAICS | NAICS Code 72 Companies, NAICS Code 7225 Companies, NAICS Code 722513 Companies, NAICS Code 72251 Companies, NAICS Code 722 Companies |
Looking for a particular BioSigma employee's phone or email?
The BioSigma annual revenue was $200000 in 2026.
BioSigma is based in Santiago, Santiago Metropolitan.
The NAICS codes for BioSigma are [72, 7225, 722513, 72251, 722].
The SIC codes for BioSigma are [58, 581].